Methylphenidate Hydrochloride 70752-0132-14
- Manufacturer
- Quagen Pharmaceuticals Llc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 4, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213567
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 10 mg/5mL |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
70752-0132-14Selected500 mL in 1 BOTTLE, PLASTIC (70752-132-14)